INTRODUCTION
Calcium ions play an extremely important and essential role in inter-and intracellular signaling pathways. It is a prominent feature of ions that they regulate diverse cellular processes in many biological systems, including the central nervous system and the immune system. Calcium-binding proteins are thought to mediate the various activities of calcium ions. VILIP-3 1 (Visinin-like protein-3) belongs to the NCS 1 (neuronal calcium sensor) protein family, which includes more than 40 intracellular calcium-sensing proteins expressed primarily in retinal photoreceptors or neurons and neuroendocrine cells (1) . The NCS protein family has some common properties as Ca 2+ sensors and switches. For instance, they show conformational changes after Ca 2+ binding. They also have two pairs of calcium-binding consensus sequences referred to as EF-hand (EF1, EF2, EF3, and EF4). They also possess a consensus myristoylation sequence at the N-terminal end, the myristoylation of which may be responsible for membrane targeting of NCS proteins in a calcium-dependent manner by a mechanism known as the "calcium-myristoyl switch" (2, 3). The NCS protein family exhibits more than 45% sequence homology and can be grouped into different subfamilies according to the amino acid similarity among various species (1, 4) . VILIP-3 belongs to a VILIPs (visinin-like proteins) subfamily, which includes Visinin-like protein-1, Visinin-like protein-2, hippocalcin, and neurocalcin in human species (5) , as well as in mice. All members of the VILIP subfamily share the major features of NCS proteins described above. There has been some confusion as regards the terminology used for the NCS protein family, as well as that used for VILIPs, because these proteins have been identified in different species and as a result have been renamed several times. To date, there are four synonyms of VILIP-3, including hHLP2 and BDR-1 from humans, NVP-3 from rats and mice, and Rem-1 from chicks. Additionally, the official reference to VILIP-3 in GeneBank is hippocalcin-like 1.
VILIP-3 expression was predominantly shown in cerebellar Purkinje cells of humans (6) and
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4 the rat brain (7), as determined by immunohistochemical studies and Western blot analysis.
By using in situ hybridization, high expression of the VILIP-3 transcript was observed in the cerebellum (Purkinje and granule cells) of the rat brain (8) . Unlike other VILIPs in this subfamily, the expression of VILIP-3 mRNA and protein has been confirmed in the peripheral tissues and in cells other than brain cells, although the expression levels were very low. Rat NVP-3 mRNA was detected in the lung, the spleen, and the skeletal muscle (9) .
Chicken Rem-1 mRNA was detected in the eye, the gut, and hematopoietic cells (10) . Rat VILIP-3 protein was detected in the kidney, the spleen, and the testis by Western blot analysis (7) . However, the physiological function of VILIP-3 remains unclear. This is the first report that murine VILIP-3 is expressed in the immune system as well as in the neural system.
In an attempt to elucidate the cellular function of murine VILIP-3, we attempted to identify proteins with which it interacts, and found that VILIP-3 interacted with microsomal cytochrome b5 in a Ca 2+ -dependent manner. Furthermore, we identified structures required for the interaction between these proteins.

EXPERIMENTAL PROCEDURES
Mice, cells, and culture conditions-C57BL/6 mice (8-10 weeks old) were obtained at our facility and from SLC (Shizuoka, Japan) and were used for RNA samples. The microglia cell line BV2 was a kind gift from Dr. E. Joe (Ajou University, South Korea). Myeloid cell line R453, SP2/0 cell line, mastocytoma cell line P815, monocyte cell line PU5, and macrophage cell line P388D1 are maintained at Memorial Sloan-Kettering Cancer Center, New York, and were made available to our laboratory by Dr. U. Hämmerling. The monocyte cell line M1
was obtained from Riken Gene Bank (Wako, Japan). T cell line 2B4-11 was provided by Dr. F-b5 (N-terminal 3×FLAG-tagged cytochrome b5) expression vector was constructed by subcloning the PCR product into the EcoRI/BamHI sites of p3×FLAG CMV 10. GST-b5
(glutathione S-transferase-tagged cytochrome b5) expression vector was obtained by subcloning the PCR product into the EcoRI/Hind III sites of pGEX-KG. All constructs were confirmed for their sequences by automated sequencing. The abbreviations for the constructs of the wild-type, described above, are summarized in Fig. 2 with their schematic representations.
Constructions of mutants and truncated-form protein expression vectors-VILIP-3
derivatives: V3-Y expression vector, described above, was used as either a template for PCR and for mutagenesis in all constructions. V3 N14-Y and V3 N25-Y (EYFP-tagged VILIP-3 truncated of N-terminal ~14 and ~25 residues) expression vectors were obtained by subcloning the PCR products into the HindIII/BamHI sites of pEYFP-N1. V3 H19~H25-Y (EYFP-tagged VILIP-3 deleted residues "H19-H25") expression vector was constructed by using a PCR overlap extension technique (12) . The truncated amino acid sequences of VILIP-3 are shown in Fig. 7A . The abbreviations used for the truncated constructs of VILIP-3 are .
E target indicates the PCR efficiency when using the VILIP-3 primer and the standard template incubated for 24 h at 4͠. Then, a 5µl bed volume of GS4B beads equilibrated by applying lysis buffer with or without calcium was added to the mixture, and the mixture was incubated for 1 h at 4͠. Finally, the beads were washed extensively in the appropriate lysis buffer, dried for a few minutes using a Speed Vac, and stored at -30͠ until use. mM DTT) for 12 h. After IPG strip rehydration, proteins bound to GS4B, prepared as described above, were eluted with sample buffer, and loaded onto IPG strips. 2-DE were performed according to the manufacturer's instructions. To visualize proteins resolved by 2-DE, silver staining of 2-DE gels was performed. Gels containing area of interest were stained with Coomassie Brilliant Blue; then, a spot of interest was selected and digested with trypsin for 16 h at 35͠. The peptide fragments generated in this manner were separated using reverse-phase HPLC. The fragments were analyzed by a protein sequencer and confirmed sequences were identified by homology searches of a CD database.
2-DE (two-dimensional electrophoresis) and amino acid sequence-The
Transfection-LipofectAMINE reagent (Invitrogen) was used for transfection of 293T cells.
For the co-immunoprecipitation experiments, 70-80% confluent 293T cells in one well of a 6-well plate were transfected using 1µg of 3×FLAG-tagged protein expression vectors and 1µg of c-myc epitope or EYFP-tagged protein expression vectors. For the in vitro binding assay
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11 using GST-tagged cytochrome b5 mutants, 70-80% confluent 293T cells in one well of a 6-well plate were transfected by 2µg of V3-F expression vector.
Co-immunoprecipitation, electrophoresis, and Western blotting-Transfected cells in one
well of a 6-well plate were lysed in 1 ml of lysis buffer (0.5% CHAPS, 50 mM HEPES (pH 7.5), 300 mM NaCl, and 1 mM CaCl 2 or EGTA) containing the protease inhibitor cocktail
Complete Mini EDTA free (Roche). Here, we examined the tissue distribution of murine VILIP-3 using real-time RT-PCR.
VILIP-3 mRNA was highly expressed in the brain and the eye. In the peripheral tissues, ubiquitous expression of VILIP-3 mRNA was observed, although the expression levels were low. In addition, the expression level of the VILIP-3 transcript was relatively high in the thymus (relative expression ratio: 0.39) compared to that of the other peripheral tissues (Fig.   1A ). In contrast to VILIP-3 expression, the expression of hippocalcin mRNA was high in the brain, but was not detected in any of the same series of peripheral tissues (Data not shown).
In a similar manner, we examined the expression of VILIP-3 mRNA in several cell lines including immunocyte lines, NIH3T3, and microglia cell line BV2. The expression levels of VILIP-3 transcripts in monocytic cell lines PU5 and M1, macrophage cell line P388D1, T cell line 2B4-11, thymocyte cell line EL-4, NIH3T3, and BV2 were relatively high compared to the levels in lymphocytic cell lines CTLL-2, SP2/0, 70Z/3, and A20. Moreover, the VILIP-3 expression in B6RVTC1 cells originating from thymoma cells was more than 3-fold higher than that of other cell lines (Fig. 1B) .
Search for a target protein of VILIP-3-In order to identify a Ca
2+
-dependent binding partner of VILIP-3, we performed a GST pull-down experiment by using GST-VILIP-3 fusion protein and B6RVTC1 cell lysates. Fig. 3 shows the 2-DE gel protein profiles. The distinct spot (a), which appeared only in the presence of calcium, was detected in silverstained 2-DE gels (Fig. 3A) . The molecular weight and isoelectric point of the spot were approximately 16-kDa and 5.2, respectively. Spot (a), detected on the Coomassie Brilliant
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13 Blue (CBB) stained gel (Fig. 4A) , was selected and subjected to an analysis of internal amino acid sequences using in-gel digestion and peptide fingerprinting methods. Two of the significant peptide fragments were submitted to amino acid sequence analysis, and the sequences were identified with N-terminal sequences involved in a highly conserved hemebinding domain of microsomal cytochrome b5 of many species (Fig. 4B) . Therefore, we confirmed that spot (a) was endogenous murine microsomal cytochrome b5. In order to provide independent evidence for the interaction between VILIP-3 and microsomal cytochrome b5 detected above, we performed a co-immunoprecipitation assay. (Fig. 5B ). These data show that VILIP-3 interacts specifically with microsomal cytochrome b5 in a calcium-dependent manner.
Identification of the minimal structural requirements of microsomal cytochrome b5 for the interaction with VILIP-3-Cytochrome b5 is a small, cylindrical, acidic membrane protein consisting of 6 helices and 5 -strands (14) . The protein is folded into two domains, namely, a globular hydrophilic domain and a smaller hydrophobic domain. The globular domain is a cytosolic heme-containing, amino-terminal, hydrophilic region, whereas the smaller domain is the hydrophobic, membrane-binding carboxyl portion of 14-18 residues, which are
14 connected in turn to the globular domain by a proline-containing hinge region of ~7 amino acids and followed by 7 polar amino acids at the very end of the polypeptide chain (15) . To determine whether the amino-terminal globular domain or the carboxyl terminal membranebinding domain of cytochrome b5 is involved in binding to VILIP-3, we carried out a coimmunoprecipitation assay by using carboxyl terminal-truncated constructs of cytochrome b5.
Although M-b5 C7 (myc-tagged cytochrome b5 truncated C-terminal ~7 residues), as well as M-b5 (myc-tagged cytochrome b5 of the wild-type), were able to bind to VILIP-3, Mb5 C15 (myc-tagged cytochrome b5 truncated C-terminal ~15 residues) was not able to carry out this interaction (Fig. 6B) . We also performed an in vitro binding assay by using affinity-purified GST-tagged cytochrome b5 mutants and V3-F (C-terminal 3×FLAG-tagged VILIP-3) bound to anti-FLAG agarose beads. Fig. 6C shows that when more than 15 amino acid residues at the end of the carboxyl terminus of cytochrome b5 were deleted, it was unable to bind to VILIP-3. Interestingly, the signal of GST-b5 C7 (GST-tagged cytochrome b5 truncated C-terminal ~7 residues) was more intense than that of GST-b5 (GST-tagged cytochrome b5 of the wild-type) sample (Fig. 6C) . Therefore, 7 polar amino acids at the very end of the carboxyl terminus appeared to inhibit the interaction between VILIP-3 and cytochrome b5. In addition, GST-b5 A120~Y127 (GST-tagged cytochrome b5 deleted GCAP-2, an NCS protein family member, interacts with guanylyl cyclase and regulates enzymatic activity. It has been shown that GCAP-2-specific amino acid residues within EF-1 can create a contact surface for binding of GCAP-2 to the cyclase (17) . We speculated that the distinct cytochrome b5-binding affinity of the two proteins occurs due to differences between amino acid residues at the N-terminal loop and EF-1; these findings indicate that there is most likely a contact surface that interacts with cytochrome b5 at these regions. To determine whether VILIP-3 interacts with cytochrome b5 through EF-1, we probed the EF-1 region of VILIP-3 by a co-immunoprecipitation assay using V3-Y mutants, which have a single mutation in the EF-1 region. The substituted residues within EF-1 are shown in Fig. 7A .
The interaction between VILIP-3 and cytochrome b5 was unaffected by any of the substitutions within EF-1 (Fig. 7B) . According to the results of a structural analysis by PROFsec, the substitution of Thr 23 with Ile would change the structure from a loop to a helix at this point. T23I (EYFP-tagged Thr 23 Ile mutant of VILIP-3) was found to bind to cytochrome b5 less intensely in this case (Fig. 7B) . Furthermore, while V3 N25-Y (EYFP-tagged VILIP-3 truncated N-terminal ~25 residues) exhibited a weak association with cytochrome b5, V3 H19~H25-Y, which was subjected to deletion of the loop around Thr 23 , was unable to bind to cytochrome b5 (Fig. 7C) . These results imply that the N-terminal loop region of VILIP-3 "H 19 -H 25 " is involved in the interaction with cytochrome b5. G2A
(EYFP-tagged Gly 2 Ala mutant of VILIP-3) and V3 N14-Y (EYFP-tagged VILIP-3 truncated N-terminal ~14 residues), which are thought to be unmyristoylated, were also bound to cytochrome b5 (Fig. 7B) . These results indicated that the N-terminal myristoylation of VILIP-3 was not necessary for binding to cytochrome b5 in vitro.
DISCUSSION
The results of our analysis of VILIP-3 expression in tissues, carried out by real-time RT-PCR, were found to be similar to those reported for other species (8, 9) . Interestingly, in the thymus, slightly higher expression of VILIP-3 was observed in comparison with that in other peripheral tissues. In addition, the thymoma cell line B6RVTC1 robustly expressed VILIP-3.
Hippocalcin is known to have 94% identity with VILIP-3 and a highly restricted tissue distribution. In contrast to hippocalcin, VILIP-3 has a ubiquitous distribution, suggesting that it may possibly play a role not only in the central nervous system, but also in the peripheral tissues, particularly in the thymus.
To our knowledge, this is the first report to identify the Ca 2+ -dependent binding partner of VILIP-3. Using a GST-pull down experiment in conjunction with 2-DE and N-terminal amino acid sequencing, we confirmed that VILIP-3 was able to associate with microsomal cytochrome b5 in a calcium-dependent manner. Moreover, in a co-immunoprecipitation assay, it was found that a Ca 2+ -dependent interaction occurred between hippocalcin and cytochrome b5. Microsomal cytochrome b5 is one of the known heme-binding proteins and functions as an electron carrier for several membrane-bound oxygenases such as cytochrome P450 (18, 19) . Three major isozymes of cytochrome b5 are known to exist. One of these is microsomal cytochrome b5, located in the endoplasmic reticulum. The second is mitochondrial cytochrome b5, which arises from a distinct microsomal-type gene. The subcellular localization of the mitochondrial type is the outer membrane of mitochondria. While the heme peptide region of the mitochondrial type is 54% identical to that of the microsomal type, the identity of their carboxyl terminal regions is only 25% in mice. The third isozyme is a soluble form of cytochrome b5 found in erythrocytes, and appears to be a splice variant of the microsomal type, although it lacks the membrane-binding carboxyl terminus. In addition to these isozymes, there are fusion enzymes containing cytochrome b5 as a component, including mitochondrial sulfite oxidase (20, 21) , the 5-and 6-fatty acid desaturases (22, 23) , and b5+b5R (24) . In the present GST pull-down assay, it was found that spot (a), which was only detected in the presence of calcium, shared the molecular weight, the isoelectric point, and the confirmed N-terminal amino acid sequences with those of the microsomal type as distinct features. As demonstrated here, the VILIP-3 binding region of cytochrome b5 is in the membrane-binding carboxyl terminus, and the soluble form of cytochrome b5 is considered unable to bind to VILIP-3. Recently, calcium-induced translocation to the perinuclear region has been observed in the case of rat hippocalcin and neurocalcin (25, 26) .
VILIP-3 is likely to have the same ability to translocate, depending on the increase in the intracellular Ca 2+ concentration; moreover, the present findings suggest that Ca
2+
-dependent target proteins exist in the perinuclear region. Therefore, microsomal cytochrome b5, which is located in the endoplasmic reticulum -perinuclear region, is well suited as a Ca 2+ -dependent binding partner of VILIP-3.
In the present study, we confirmed that the region "V 114 -Y
127
" at the C-terminal membrane-binding domain of cytochrome b5 is the minimal essential structure for the interaction with VILIP-3. The function of the membrane-binding domain of cytochrome b5 is believed to be the anchoring of cytochrome b5 to the membrane of the endoplasmic reticulum by its hydrophobic stretch of ~23 amino acids, and this region is thought to orient the catalytic site at the membrane-aqueous interface to permit rapid electron transfer (27, 28) . It has been known that cytochrome b5 is synthesized on cytosolic ribosomes and is posttranslationally inserted into the microsomal membranes independent of signal recognition particles (29, 30) . Although the ten C-terminal residues are thought to be essential for targeting to the membrane (31), it is not known whether the insertion into the membrane occurs spontaneously or by a receptor-mediated mechanism. In some attempts to elucidate the machinery of targeting the protein into the membrane, two different modes of binding to
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20 artificial liposomes have been demonstrated in vitro. A "loose-binding form" is obtained when cytochrome b5 is mixed with preformed liposomes (32) . Alternatively, in the presence of detergent, a "tight-binding form" is obtained (33) . To date, two different models of conformation have been proposed for the membrane-binding domain: 1) a single membranespanning helix and 2) a hairpin-type structure, which would result from isomerization of the trans Ile 114 Pro 115 amide bond to the cis amide bond; the membrane-binding domain is thought to span only half of the bilayer in this case (Fig. 4C) (34) . A few studies have suggested that the tight-binding form might represent a membrane-spanning conformation (19, (35) (36) (37) . No examples of stable integral membrane protein structures that span only one-half of the bilayer in a hairpin conformation have been identified in the high-resolution X-ray structures of the membrane proteins determined to date. However, it has been reported in one study that the tight-binding form is a hairpin conformation (33) , and other studies have suggested that both the tight and loose forms are hairpin structures (38) . In addition, computer modeling of the three-dimensional structure of full-length cytochrome b5 has indicated that the membranebound part forms a loop structure (39) . In another paper, it was shown that the peptide could flip between two alternative conformations under conditions of changing temperature (40) .
Thus, the topology of the membrane-binding domain still remains to be determined.
Interestingly, the VILIP-3 binding sequence of cytochrome b5 indicated in this study included a Pro 115 residue. As VILIP-3 exists in cytosol, it is possible that a hairpin-loop conformation may be more accessible to VILIP-3 than a single-helix transmembrane conformation, assuming that the helix following Pro 115 within the VILIP-3 binding region exists on the cytosolic side of the bilayer in a hairpin-loop conformation (Fig. 4C) . In any case, as it is clear that the VILIP-3 binding sequence of cytochrome b5 exists within the membrane of the ER 1 , the interaction between VILIP-3 and cytochrome b5 must occur within the hydrophobic core of the membrane.
21
We also confirmed that the N-terminal loop "H 19 -H   25 " of VILIP-3 was necessary for binding to cytochrome b5. However, the hydrophilic loop region, without any assistance, is not likely to be integrated into the hydrophobic core of the ER membrane and not directly attach to the C-terminal hydrophobic tail of cytochrome b5. We take note of the very hydrophobic helix "L 89 -G
95
" lying between EF-2 and conserved Gly
, which is known to be a point of rotation following Ca 2+ -binding. In the analysis of hydrophobicity, the region "L 89 -G 95 " exhibited the most pronounced hydrophobicity throughout the full length of VILIP-3 (Fig. 8) . According to the three-dimensional structure of Ca 2+ bound form of bovine neurocalcin , which has a similar hydrophobic profile to that of VILIP-3 ( Fig. 8) bound neurocalcin (Fig. 9) . Interestingly, Asp 21 adjoins to Arg 94 in the local environment within the amphipathic structure (Fig. 9) . The charge-charge interaction on these neighboring oppositely charged residues may stabilize the local amphipathic conformation of Ca However, we suppose that the myristoylated N-terminal end of VILIP-3 may be necessary for the membrane targeting and facilitate the integration of VILIP-3 to the membrane together with the amphipathic structure in situ.
Cytochrome b5 is known to function as an electron transfer component in a number of The left two lanes, whole cell lysates; the right four lanes, immunoprecipitated samples. Underlined bold letters indicate the residues of hippocalcin that differed from those of VILIP-3. The schematic representations of the constructs are summarized in Fig. 2B . B, Coimmunoprecipitation assay using F-b5 and single amino acid-substituted mutants of V3-Y.
293T cells were transfected with each expression vector, shown on the top of the gel. All transfectants were lysed in the presence of calcium. The interacting proteins were detected by
